Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00006374 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Lung Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: cisplatin
DRUG: etoposide
DRUG: paclitaxel
DRUG: topotecan hydrochloride

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]